Quick Answer: Cervical cancer is a form of cancer that originates in the cells of the cervix, which is the lower and narrow section of the uterus that links to the vagina.
Introduction
Cervical cancer occurs in the cervix, which is the lower section of the uterus and joins the vagina. Almost all cases of cervical cancer are caused by a persistent infection with certain high-risk types of human papillomavirus (HPV). Since HPV infection is very common and usually clears on its own, a persistent infection can lead to abnormal changes in the cells of the cervix. If these changes are not detected and treated by healthcare professionals, they may eventually develop into cancer.
The good news is that cervical cancer is mostly preventable, since vaccination against HPV, regular screening, early diagnosis, and prompt treatment can all greatly reduce the chances of either developing the disease or dying from it.
What Causes Cervical Cancer?
The presence of a high-risk type of HPV is at the heart of cervical cancer. This virus is mainly transmitted by sexual contact, and most people who have sexual relations will, at some stage in their lives, become infected. However, in the majority of cases, the immune system is able to eliminate the infection without causing any serious issues.
But if a high-risk HPV infection lasts for several years, it may lead to changes in the cervical cells; these abnormal cells can progress to precancerous lesions and, if not treated, will eventually turn into cancer. HPV types 16 and 18 are among the most important of the high-risk types and account for a large share of cervical cancers around the world.
Risk Factors
Several factors can increase the chance that an HPV infection will last and develop into cervical cancer. They are:
Persistent Infection With High-Risk HPV
The continued infection with high-risk human papillomavirus (HPV) is the main risk factor for cervical cancer. In a great many individuals, the immune system is able to get rid of the HPV on its own. But if high-risk HPV stays in the body for several years, it may lead to abnormal changes in the cells of the cervix. If these changes are not properly monitored and treated, they can slowly progress to cervical cancer.
A Weakened Immune System
Because the immune system is weakened, it becomes harder for the body to control or get rid of an HPV infection; as a result, individuals who have conditions or treatments that suppress immune function may be at greater risk of having a persistent HPV infection and of showing cervical cell abnormalities. Such people need to have regular screening.
HIV Infection
Since people living with HIV have a weakened immune system due to the virus, they are at greater risk of developing cervical cancer as it becomes more difficult for them to eliminate high-risk HPV infections, and the HPV infections may last for longer periods and result in cervical abnormalities. The risk of cervical cancer can be reduced by having regular cervical cancer screenings and by properly managing any abnormal results.
Smoking or Exposure to Tobacco Smoke
For people who have an HPV infection, smoking may increase their risk of developing cervical cancer. The chemicals in tobacco smoke can damage the cells of the cervix and might hinder the body’s ability to combat the HPV infection. It follows that giving up tobacco and stopping smoking can help improve cervical health and lower the risk of cancer.
Certain Reproductive Factors
Certain reproductive factors have been linked to a higher risk of cervical cancer. For instance, studies have discovered associations between cervical cancer and factors including the long-term use of particular hormonal contraceptives. Yet these factors do not, on their own, cause cervical cancer; the total risk varies according to several individual and HPV-related factors.
Multiple Pregnancies
The fact that a woman has had several full-term pregnancies has been linked to a greater risk of cervical cancer, especially in those with a persistent high-risk HPV infection. Researchers think that the hormonal changes, immune changes, and the repeated alterations to the cervix that take place during pregnancy may be responsible for this association. Nevertheless, having multiple pregnancies does not imply that a woman will develop cervical cancer.
Early Sexual Activity
Beginning sexual activity at a younger age may lengthen the period during which a person is exposed to HPV. As HPV is mainly transmitted through sexual contact, having sexual contact at an earlier age could increase the chance of picking up HPV. Since a person has more than one sexual partner, the chance of picking up HPV rises as each new sexual partner may provide another opportunity for exposure to the virus. Yet HPV can still be passed on between people who have had only one sexual partner. The use of condoms can reduce the risk of transmission of HPV, but they cannot offer full protection since the virus can infect areas that are not covered by the condoms.
g up the virus. The risk of developing cervical cancer is mainly dependent on whether a high-risk HPV infection persists and leads to abnormal changes in the cervix.
Having Multiple Sexual Partners
The fact that these factors exist does not mean that a person will certainly develop cervical cancer; they only increase the risk, especially in the case of a persistent high-risk HPV infection.
Recognizing the Symptoms
Cervical cancer often does not show any symptoms in its early stages, which is why it is so important to have regular screenings.
When symptoms occur, they may include:
Vaginal bleeding after sexual intercourse
Vaginal bleeding following sexual intercourse, a condition referred to as postcoital bleeding, may act as an early indication of cervical cancer. This kind of bleeding can take place because cancerous or abnormally developed cells on the cervix can make the tissue more fragile and cause it to bleed when it comes into contact. Even though there are several other possible causes of postcoital bleeding, any bleeding that is persistent or unexplained should be assessed by a healthcare professional.
Bleeding between menstrual periods
Women with cervical cancer may experience bleeding or spotting between their usual menstrual periods. The bleeding might be irregular and could take the form of light spotting or more obvious bleeding outside of the normal menstrual cycle. As bleeding between periods can also be caused by hormonal changes, infections, or other gynecological conditions, any unusual or continuous bleeding should be evaluated by a healthcare professional.
Heavier or longer menstrual periods
Cervical cancer can cause menstrual periods to become heavier or to last for a longer time than normal. The changes in the cervix and the abnormal blood vessels connected with the disease can lead to increased bleeding. Women who observe a noticeable or ongoing change in their normal menstrual pattern should talk to a healthcare professional.
Vaginal bleeding after menopause
Vaginal bleeding after menopause is regarded as abnormal and might be a possible sign of cervical cancer. The bleeding can vary from light spotting to heavier bleeding and should not be ignored even if it happens only once. Since there are several possible reasons for bleeding after menopause, it is important to have a medical examination to find out the cause underneath.
Unusual vaginal discharge
Vaginal discharge may be affected by cervical cancer, and in such cases it can become watery, heavier than normal, have a strong smell, or be stained with blood. Such changes can happen when abnormal cells influence the cervix and the surrounding tissues. Since abnormal discharge can also be the result of infections and other conditions, anyone experiencing persistent or unusual discharge should have it looked at by a healthcare professional.
Pelvic pain
Pelvic pain can arise in cases of cervical cancer, especially when the disease has advanced and has affected adjacent tissues or structures; the pain might be continuous,s or it might be experienced in the lower abdomen, pelvis, or lower back. Anyone experiencing unexplained or persistent pelvic pain should have it medically evaluated to find out the cause.
Pain during sexual intercourse
Dyspareunia, which is pain experienced during sexual intercourse, can be linked to cervical cancer. This kind of pain might happen when abnormal growth or changes in the cervix and the tissues surrounding it lead to discomfort at the time of intercourse. Nevertheless, there are numerous possible reasons for painful intercourse, so anyone experiencing persistent or unexplained pain should consult a healthcare professional.
Advanced disease can lead to difficulty or pain when urinating or having bowel movements, the presence of blood in the urine or in the stool, back pain, abdominal pain, swelling in the legs, or ongoing tiredness. Since these symptoms may also be caused by conditions other than cancer, a healthcare professional must assess any persistent or unusual symptoms.
How Doctors Diagnose Cervical Cancer
To investigate abnormal screening results or symptoms, healthcare professionals employ a number of methods, such as taking a medical history, carrying out a physical and pelvic examination, performing HPV testing, conducting a Pap test, carrying out a colposcopy, and taking a biopsy.
A colposcopy enables a healthcare professional to examine the cervix in more detail and spot any abnormal areas. In the case of a biopsy, the healthcare professional removes a small piece of tissue and sends it off for laboratory examination. It is possible for a biopsy to confirm the presence of cancer cells.
Cervical Cancer Screening
Screening allows healthcare professionals to spot changes in cervical cells before these changes turn into cancer and may also pick up some cancers in their early stages, when treatment is usually easier.
Common screening methods include:
HPV Test
The HPV test tests the cervical cells for those high-risk types of HPV that can lead to cervical cancer.
Pap Test
The Pap test, which is also known as a Pap smear or cervical cytology test, looks for abnormal changes in the cervical cells.
HPV/Pap Co-testing
This method involves carrying out HPV testing together with an examination of cervical cells. The right test and the interval between screenings will vary according to factors such as a woman’s age, her medical history, and the national guidelines.
People who have had the HPV vaccine should still have the cervical screening that is recommended since the HPV vaccine does not offer protection against all high-risk types of HPV.
HPV Vaccination: A Powerful Prevention Tool
The HPV vaccine can prevent infection with those HPV types which cause cervical cancer; it gives the best results when people get it before they are exposed to the virus, which is the reason why health authorities focus on vaccinating adolescents. The World Health Organization considers HPV vaccination to be a key element of cervical cancer prevention.
The vaccine can stop new HPV infections but cannot be used to treat an existing HPV infection or existing cervical cancer; it is therefore necessary for vaccination and regular screening to be used together in order to achieve better protection.
Can You Lower Your Risk?
You can take several steps to lower your risk of cervical cancer:
Follow the recommended schedule for getting the HPV vaccine.
- Adhere to the guidelines for cervical cancer screening.
- Do not smoke or be exposed to tobacco.
- When you are having sex, make sure to practise safer sex, which includes using condoms, keeping in mind that condoms do not offer full protection against HPV.
- You must go in for your follow-up appointments if a screening test shows an abnormal result.
- See a doctor if you have unusual vaginal bleeding, discharge, or pelvic pain.
- It is still important to have regular screening since early cancer changes usually do not cause any symptoms.
Treatment Options
Surgery
Surgery is generally employed in cases where the tumour is localised and can be removed together with any surrounding tissue that has been affected. The doctors first decide if the cancer is limited enough for the operation to be both effective and safe, and the surgery can either be used by itself or in combination with other treatments to deal with any remaining cancer cells.
Radiation Therapy
Radiation therapy involves the use of high-energy beams, for example X-rays or protons, in order to damage the DNA of cancer cells and thus destroy their ability to grow and to divide; it can be directed accurately at the site of the tumour so as to reduce damage to the surrounding healthy tissue and is generally employed either before surgery to shrink the tumour or after surgery to get rid of any remaining cancer cells.
Chemotherapy
Chemotherapy makes use of drugs which pass through the bloodstream in order to aim at cancer cells that are dividing rapidly all over the body, which is why it is particularly useful in cases where the cancer has spread from its original location. It may be administered either orally or by injection, usually in cycles. Although it is effective at destroying cancer cells, it may also have an effect on some normal cells, causing side effects such as fatigue or hair loss.
Targeted Therapy
Targeted therapy involves the use of drugs which are designed to detect and attack specific molecules or genetic mutations present in cancer cells, thereby leaving the normal, healthy cells more unharmed than traditional chemotherapy does. In order to use this method, it is necessary to test the tumour’s particular features beforehand in order to assess whether a targeted drug is likely to be effective in the case of that kind of cancer.
Immunotherapy
Immunotherapy functions by enhancing or re-establishing the body’s immune system in its ability to identify and eliminate cancer cells, cancer cells which would otherwise manage to escape detection by the immune system. It has demonstrated considerable promise in the case of some kinds of cancer and is different from other kinds of therapy in that it makes use of the patient’s own biological defences instead of carrying out the direct external destruction of cancer cells.
Why Early Detection Matters
Cervical cancer usually develops slowly after a persistent infection with a high-risk type of HPV has caused precancerous changes. Screening can detect these changes before they turn into cancer, and then healthcare professionals can treat the precancerous lesions in order to prevent cancer from developing.
The WHO advocates a comprehensive strategy which includes vaccinating against HPV, carrying out screening, treating precancerous lesions, and providing prompt treatment for cervical cancer.
A Message for Every Woman
Cervical cancer should never be a surprise. Prevention involves becoming aware of the risks, getting vaccinated, and having regular screenings. When you experience unusual bleeding, an abnormal discharge, pelvic pain, or any other persistent symptoms, you should not ignore them. You must consult a healthcare professional and have them carry out the proper evaluation.
If we implement effective prevention measures and detect cases early, we will be able to lessen the impact of cervical cancer and take a step towards eliminating it as a public health issue.
Frequently Asked Questions
1. What is the main cause of cervical cancer?
Persistent infection by high-risk types of human papillomavirus (HPV) is the main cause of cervical cancer. Human papillomavirus is a sexually transmitted infection that is common in many people and, in most cases, goes away. However, in cases where it persists, it causes cell changes to develop into cancer.
2. Who is at risk for cervical cancer?
Any woman or female-bodied person who has had sexual activity before is vulnerable to developing cervical cancer because of the HPV virus. There is an increased likelihood of having cervical cancer if you have a habit of smoking, are immunocompromised, or do not undergo screening.
3. Can cervical cancer return after treatment?
Yes, cervical cancer may recur even after treatment. Recurrence normally occurs within the first 2-3 years. The probability of recurrence is dependent upon the stage of cervical cancer at diagnosis, size of the tumor, and spread to the lymph nodes.
4. How fast does cervical cancer spread?
It is common for cervical cancer to grow at a slow pace. In general, a patient takes about 10 to 20 years after having an infection with the virus to develop abnormal cells, which later change into a precancerous form and then develop into cancer. Nevertheless, once the abnormal cells have developed into cancer, the speed may increase, depending on the nature of the tumor.
5 . What are the signs that cervical cancer is nearing death?
For someone who is approaching the end of their life due to advanced cervical cancer, there will be many physical changes that occur within the body. Some general symptoms of dying due to cancer are excessive fatigue, sleeping all the time, loss of appetite, difficulty swallowing, and pale, mottled skin due to poor circulation.
Conclusion
Cervical cancer is a disease which, if picked up early, can be both prevented and treated. By knowing the factors that increase the risk of the disease and by identifying warning signs such as abnormal vaginal bleeding, an unusual vaginal discharge, pelvic pain, and pain during sexual intercourse, women may be encouraged to get medical help early. It is important to have regular screenings for cervical cancer, to receive the HPV vaccine, and to follow up properly on any abnormal screening results if they occur, all of which contribute to prevention and early detection. Staying aware and seeking advice from a healthcare professional when odd symptoms appear can help to improve treatment outcomes and lessen the impact of cervical cancer.
REFERENCES:
1.Li T, Zhang H, Lian M, He Q, Lv M, Zhai L, et al. Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021. Journal of Hematology & Oncology. 2025 Jan 10;18(1). https://pubmed.ncbi.nlm.nih.gov/39794860/
2. Johnson CA, James D, Marzan A, Armaos M. Cervical Cancer: An Overview of Pathophysiology and Management. Seminars in Oncology Nursing. 2019 Apr;35(2):166–74. https://pubmed.ncbi.nlm.nih.gov/39794860/
3.Sikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, et al. Cervical cancer: screening, diagnosis and staging. Journal of BUON: official journal of the Balkan Union of Oncology [Internet]. 2016 Mar 1 [cited 2026 Aug 29];21(2):320–5. Available from: https://pubmed.ncbi.nlm.nih.gov/27273940/
4.Nartey Y, Kwabena Amo‐Antwi, Hill PC, Edward T. Dassah, Richard H. Asmah, Nyarko KM, et al. Risk Factors for Cervical Cancer in <scp>Ghana</scp>. Cancer Reports. 2024 June 1;7(6). https://pubmed.ncbi.nlm.nih.gov/39031901/
5.Ray A. Human Papillomavirus and Other Relevant Issues in Cervical Cancer Pathogenesis. International Journal of Molecular Sciences [Internet]. 2025 June 10 [cited 2026 Aug 29];26(12):5549–9. Available from: https://www.mdpi.com/1422-0067/26/12/5549
6.Francoeur AA, Monk BJ, Tewari KS. Treatment advances across the cervical cancer spectrum. Nature Reviews Clinical Oncology [Internet]. 2025 Mar [cited 2026 Aug 29];22(3):182–99. Available from: https://www.nature.com/articles/s41571-024-00977-w
7.Moore DH. Cervical Cancer. Obstetrics & Gynecology [Internet]. 2006 May [cited 2026 Aug 29];107(5):1152–61. Available from: https://journals.lww.com/greenjournal/fulltext/2006/05000/cervical_cancer.28.aspx
